occurs in has participant quality has disease treated with drug INTERFERON ALFA-2A TOPOTECAN IFOSFAMIDE CARBOPLATIN MITOXANTRONE HYDROCHLORIDE DOXORUBICIN METHOTREXATE PACLITAXEL DOCETAXEL LEFLUNOMIDE BEXAROTENE SORAFENIB IXABEPILONE CABAZITAXEL ERIBULIN VEMURAFENIB TERIFLUNOMIDE mature T-cell and NK-cell lymphoma secondary progressive multiple sclerosis prostate cancer lung cancer breast cancer melanoma multiple sclerosis ovarian cancer hairy cell leukemia testicular cancer hepatocellular carcinoma rheumatoid arthritis chronic myeloid leukemia Kaposi's sarcoma acute myeloid leukemia Elderly Child Adult hair AE alopecia AE 10001760 VAE, MW HPO: HP_0001596 alopecia means the absence of hair or loss of hair. It is not usually in reference to primary genetic hairlessness but may be due to dietary, stress, secondary to immune condition. CTCAE:E13611 MP: MP_0000414 a hair AE that has an outcome of alopecia and occurs after a medical intervention. SIDER: C0002170 NCIt:C50575 AE severity G1 AE severity G2